# Julie Rubinstein

Type: Person

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/julie-rubinstein
Canonical HTML page: https://gethealthbrief.com/entity/julie-rubinstein

## Timeline

- **2026-03-14**: Insider Sales Reported — SEC filings confirm share liquidations by COO Julie Rubinstein and SVP Susan Bobulsky.
- **2026-02-15**: Q4 2025 Earnings — Adaptive reports continued growth in clonoSEQ test volume and revenue.
- **2025-11-10**: Clinical Expansion — Company announces new data supporting T-cell mapping in autoimmune research.

## Recent coverage (1 stories)

### Adaptive Biotechnologies Insiders Sell Over 60,000 Shares Amid Market Shift
2026-03-14 03:48:22 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Adaptive Biotechnologies (NASDAQ: ADPT) executives Julie Rubinstein and Susan Bobulsky have sold a combined 60,398 shares, signaling a notable period of insider liquidation. The transactions occur as the company continues to navigate the competitive landscape of immune-driven diagnostics and MRD monitoring.
Full story: https://gethealthbrief.com/story/adaptive-biotechnologies-insider-selling-march-2026

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.